In TA, screening based on a 440-cytokine protein array [53] identified higher plasma levels of tissue inhibitor of metalloproteinases (TIMP)-1, P-cadherin and MMP-9 and lower levels of WNT inhibitory factor (WIF)-1 in the plasma of TA patients as compared to healthy controls. The gene discussed is CDH3; the disease is Takayasu arteritis.